Silvercrest Asset Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Silvercrest Asset Management’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-467,001	Closed	-$8.16M	–	897
2020 Q4	$8.16M	Sell	467,001 -80,024	-15%	-$1.12M	0.06%	274
2020 Q3	$6.4M	Sell	547,025 -10,581	-2%	-$140K	0.05%	291
2020 Q2	$7.25M	Buy	557,606 +114,027	+26%	+$1.37M	0.06%	253
2020 Q1	$4.11M	Sell	443,579 -1,033	-0.2%	-$14.4K	0.04%	311
2019 Q4	$7.38M	Sell	444,612 -19,122	-4%	-$310K	0.06%	273
2019 Q3	$7.71M	Buy	+463,734	New	+$6.41M	0.06%	248

Silvercrest Asset Management's OXFD Position: Q1 2021 in Review

Silvercrest Asset Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 467,001 shares — an estimated $8.16M sold.

Silvercrest Asset Management first reported a position in OXFD in Q3 2019 and held it in 6 quarters. The position peaked at $8.16M in Q4 2020. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.

Silvercrest Asset Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
Silvercrest Asset Management sold 467,001 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $8.16M.
Silvercrest Asset Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q3 2019 and held it in 6 quarters.
Silvercrest Asset Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $8.16M in Q4 2020.
0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.

Based on Silvercrest Asset Management's 13F filing for Q1 2021, filed 17 May 2021.